Samsung Bioepis wins FDA approval for rheumatoid arthritis drug that competes with Johnson & Johnson
April 22, 2017 at 00:02 AM EDT
Samsung Bioepis has won regulatory approval for key biosimilar drug, the first time the company's product has been approved for U.S. use.
